Ma-Spore ALL 2020 Study

NCT06336395 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

B Lymphoblastic Leukemia

Interventions

DRUG: Prednisolone
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Methotrexate
DRUG: L-Asparaginase
DRUG: Pegylated asparaginase
DRUG: Erwinase
DRUG: Dasatinib
DRUG: Imatinib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Thioguanine
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Fludarabine

Sponsor

National University Hospital, Singapore